D. E. Shaw & Co., Inc. - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$838,812
-42.9%
42,215
-50.8%
0.00%
-50.0%
Q1 2023$1,468,812
-58.8%
85,745
-52.9%
0.00%
-50.0%
Q4 2022$3,564,910
-50.2%
182,162
-59.4%
0.00%
-55.6%
Q3 2022$7,156,000
+176.2%
448,342
+138.1%
0.01%
+200.0%
Q2 2022$2,591,000
-14.7%
188,301
-1.7%
0.00%0.0%
Q1 2022$3,037,000
-8.2%
191,512
+26.4%
0.00%0.0%
Q4 2021$3,307,000
-40.3%
151,494
-18.3%
0.00%
-40.0%
Q3 2021$5,542,000
-37.4%
185,434
-7.3%
0.01%
-37.5%
Q2 2021$8,859,000
-34.8%
200,018
-34.7%
0.01%
-38.5%
Q1 2021$13,589,000
-22.2%
306,250
-3.9%
0.01%
-18.8%
Q4 2020$17,474,000
+247.6%
318,638
+44.9%
0.02%
+220.0%
Q3 2020$5,027,000
+6.2%
219,879
-2.8%
0.01%
-16.7%
Q2 2020$4,734,000
+63.6%
226,202
+9.1%
0.01%
+20.0%
Q1 2020$2,893,000
+590.5%
207,403
+1025.5%
0.01%
Q4 2019$419,000
+153.9%
18,427
+65.0%
0.00%
Q4 2018$165,000
-73.3%
11,166
-55.4%
0.00%
-100.0%
Q3 2018$617,000
-45.6%
25,056
-56.6%
0.00%0.0%
Q2 2018$1,134,000
-56.6%
57,750
-58.5%
0.00%
-75.0%
Q1 2018$2,610,000139,2000.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,037,486$280,250,00019.13%
TANG CAPITAL MANAGEMENT LLC 2,965,485$52,015,0009.58%
Boxer Capital, LLC 1,466,051$25,715,0002.97%
Ghost Tree Capital, LLC 600,000$10,524,0002.75%
BRIDGER MANAGEMENT, LLC 1,529,032$26,819,0002.12%
Cormorant Asset Management, LP 1,700,000$29,818,0002.02%
EcoR1 Capital, LLC 450,000$7,893,0000.73%
UNIVERSITY OF NOTRE DAME DU LAC 171,015$3,000,0000.67%
Virtus ETF Advisers LLC 17,799$312,0000.66%
SPHERA FUNDS MANAGEMENT LTD. 290,001$5,087,0000.46%
View complete list of ROCKET PHARMACEUTICALS INC shareholders